NLS PHARMACEUTICS LTD

CUSIP: H57830111 Class: *W EXP 02/02/202

Altium Capital Management LP's Holding History (CIK: 0001746382)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 200,000 Value ($000) $2 Avg Close — Range —
Q2 2024
Shares 200,000 Value ($000) $7 Avg Close — Range —
Q1 2024
Shares 200,000 Value ($000) $7 Avg Close — Range —
Q4 2023
Shares 200,000 Value ($000) $11 Avg Close — Range —
Q3 2023
Shares 200,000 Value ($000) $21 Avg Close — Range —
Q2 2023
Shares 200,000 Value ($000) $21 Avg Close — Range —
Q1 2023
Shares 200,000 Value ($000) $30 Avg Close — Range —
Q4 2022
Shares 200,000 Value ($000) $38 Avg Close — Range —
Q3 2022
Shares 200,000 Value ($000) $43 Avg Close — Range —
Q2 2022
Shares 200,000 Value ($000) $24 Avg Close — Range —
Q1 2022
Shares 200,000 Value ($000) $76 Avg Close — Range —
Q4 2021
Shares 200,000 Value ($000) $146 Avg Close — Range —